R&D Focus

R&D Focus
NLS Pharmaceutics is active in the field of cognitive enhancement and neuro somatic therapies in particular. These disorders remain largely under-diagnosed and current therapies lack in safety and effectiveness:
  • Attentional Disorders (ADHD, ADD, Deficit of alertness)
  • Excessive Daytime Sleepiness (Narcolepsy, Hypersomnias)
  • Pervasive Developmental Disorders (ASD, Oligophrenia)
  • Iron Cerebral Insufficency (Neuro-Anemia Syndrome, RLS)
  • Cognitive Impairments (MCI, AD)
  • Synucleopathies (PD, LB)
  • Primary Insomnia (SOI)